Pregled bibliografske jedinice broj: 41562
Molecular mechanism involved in the antiproliferative action of protein tyrosine phosphatase inhibitor potassium bisperoxo(1, 10-phenanthroline)oxovanadate
Molecular mechanism involved in the antiproliferative action of protein tyrosine phosphatase inhibitor potassium bisperoxo(1, 10-phenanthroline)oxovanadate // Life sciences, 68 (2000), 2; 165-175 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 41562 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Molecular mechanism involved in the antiproliferative action of protein tyrosine phosphatase inhibitor potassium bisperoxo(1, 10-phenanthroline)oxovanadate
Autori
Ban, Jasna ; Maysinger Dušica ; Kovač, Višnja ; Galetić, Ivana ; Matulić, Maja ; Hadžija, Mirko ; Užarević, Branka
Izvornik
Life sciences (0024-3205) 68
(2000), 2;
165-175
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
protein tyrosine phosphatases; peroxovanadium derivative; differentiation; cell cycle; apoptosis; HL-60 leukemia cells
Sažetak
Potassium bisperoxo(1, 10-phenanthroline)oxovanadate, bpV(phen), a powerful protein phosphotyrosine phosphatase inhibitor and a potent insulinomimetic, influenced three fundamental cellular processes in HL-60 human leukemic cells: 1) inhibition of proliferation, 2) induction of differentiation and 3) apoptotic cell death. In the presence of micromolar concentrations of bpV(phen) cell number and DNA synthesis decreased progressively with time of incubation. A single treatment with bpV(phen) (3 uM) activated a differentiation program ; after 6 days of incubation 82% of cells were differentiated, but differentiation started already within the first 24 h. Concentrations of 5-10 uM bpV(phen) caused the characteristic DNA ladder pattern, starting after 4.5 h. Differentiation in HL-60 cells appear to be associated with activation of extracellular signal-regulated kinase while apoptosis is connected with phosphorylation and activation of both extracellular signal-regulated kinase and c-Jun N-terminal kinase in a concentration and time-dependent manner. The antiproliferative and apoptotic action of bpV(phen) could be exploited in combination chemotherapy in leukemia.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Institut "Ruđer Bošković", Zagreb,
Prirodoslovno-matematički fakultet, Zagreb
Profili:
Mirko Hadžija
(autor)
Jasna Ban
(autor)
Branka Užarević
(autor)
Maja Matulić
(autor)
Višnja Kovač
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Biological Abstracts